metastatic/advanced - colorectal cancer (mCRC) | |
mCRC - 2nd line (L2) | |
avelumab based treatment | |
avelumab alone | SAMCO-PRODIGE 54 |
Study type:
delta: difference in rate or median (if available)
- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy -